269 related articles for article (PubMed ID: 25857234)
1. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
2. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
3. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
5. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
Mehta DC; Short JL; Nicolazzo JA
Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
[TBL] [Abstract][Full Text] [Related]
6. Transport characteristics of tramadol in the blood-brain barrier.
Kitamura A; Higuchi K; Okura T; Deguchi Y
J Pharm Sci; 2014 Oct; 103(10):3335-41. PubMed ID: 25175482
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
10. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
Kitamura A; Higuchi K; Kurosawa T; Okura T; Kubo Y; Deguchi Y
Biol Pharm Bull; 2022; 45(10):1585-1589. PubMed ID: 36184519
[TBL] [Abstract][Full Text] [Related]
12. Contribution of pannexin 1 and connexin 43 hemichannels to extracellular calcium-dependent transport dynamics in human blood-brain barrier endothelial cells.
Kaneko Y; Tachikawa M; Akaogi R; Fujimoto K; Ishibashi M; Uchida Y; Couraud PO; Ohtsuki S; Hosoya K; Terasaki T
J Pharmacol Exp Ther; 2015 Apr; 353(1):192-200. PubMed ID: 25670633
[TBL] [Abstract][Full Text] [Related]
13. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
15. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
[TBL] [Abstract][Full Text] [Related]
16. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
[TBL] [Abstract][Full Text] [Related]
17. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
19. The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.
Dos Santos Pereira JN; Tadjerpisheh S; Abu Abed M; Saadatmand AR; Weksler B; Romero IA; Couraud PO; Brockmöller J; Tzvetkov MV
AAPS J; 2014 Nov; 16(6):1247-58. PubMed ID: 25155823
[TBL] [Abstract][Full Text] [Related]
20. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
